Somatostatin receptor molecular imaging in a misdiagnosed gastrinoma case
- PMID: 33623513
- PMCID: PMC7875036
- DOI: 10.4103/wjnm.WJNM_16_20
Somatostatin receptor molecular imaging in a misdiagnosed gastrinoma case
Abstract
Gastrin-secreting tumors, hypergastrinemia and severe ulcer disease form the trademarks of Zollinger-Ellison syndrome (ZES). We report a case of gastrinoma, in a patient who was misdiagnosed for almost five years. The case emphsizes the the special role of functional imaging in the personalized approach to the patient with suggestive symptomatology for NETs. Taking into account that in 80 to 100% of cases of gastroenteropancreatic (GEP) NETs are expressing somatostatin receptors, the functional imaging with radiolabeled somatostatin analogues can be used in order to improve its diagnosis, respectively the treatment of GEP NETs. In the approach to the patient with tremendous digestive symptomatology, physicians from different specialties should evaluate NETs specific markers and then insist on structural-functional complementarity, avoiding the waste of time and high cost of repeated structural investigations. The conclusion of our study is that functional imaging is mandatory in the diagnostic algorithm of gastrinoma.
Keywords: Functional imaging; gastrinoma; hypergastrinemia; neuroendocrine tumors; somatostatin receptor scintigraphy.
Copyright: © 2020 World Journal of Nuclear Medicine.
Conflict of interest statement
There are no conflicts of interest.
Figures



Similar articles
-
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?Endocrine. 2018 Apr;60(1):15-27. doi: 10.1007/s12020-017-1420-4. Epub 2017 Oct 10. Endocrine. 2018. PMID: 29019150 Review.
-
[Somatostatin receptor scintigraphy in neuroendocrine tumors exemplified by a patient with hepatic metastases of gastrinoma].Z Gastroenterol. 1994 Feb;32(2):100-4. Z Gastroenterol. 1994. PMID: 7513113 German.
-
Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.World J Surg Oncol. 2019 Dec 9;17(1):213. doi: 10.1186/s12957-019-1758-6. World J Surg Oncol. 2019. PMID: 31818296 Free PMC article.
-
A Rare Case of Hepatic Gastrinoma.Cureus. 2023 Aug 12;15(8):e43383. doi: 10.7759/cureus.43383. eCollection 2023 Aug. Cureus. 2023. PMID: 37700944 Free PMC article.
-
Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view.Panminerva Med. 2006 Mar;48(1):33-40. Panminerva Med. 2006. PMID: 16633330 Review.
References
-
- Guarnotta V, Martini C, Davì MV, Pizza G, Colao A, Faggiano A, et al. The Zollinger-Ellison syndrome: Is there a role for somatostatin analogues in the treatment of the gastrinoma? Endocrine. 2018;60:15–27. - PubMed
-
- Dromain C, Déandréis D, Scoazec JY, Goere D, Ducreux M, Baudin E, et al. Imaging of neuroendocrine tumors of the pancreas. Diagn Interv Imaging. 2016;97:1241–57. - PubMed
-
- O'Toole D, Fave GD, Jensen RT. Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012;26:719–35. - PubMed
-
- Mendelson AH, Donowitz M. Catching the zebra: Clinical pearls and pitfalls for the successful diagnosis of Zollinger-Ellison syndrome. Dig Dis Sci. 2017;62:2258–65. - PubMed
Publication types
LinkOut - more resources
Full Text Sources